Integra Lifesciences Holdings (IART) EBT Margin Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 12,889.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,889.00 |
| Mar 31, 2026 | 723.00 |
| Dec 31, 2025 | -410.00 |
| Sep 30, 2025 | 365.00 |
| Jun 30, 2025 | -12,412.00 |
| Mar 31, 2025 | -643.00 |
| Dec 31, 2024 | -218.00 |
| Sep 30, 2024 | -1,021.00 |
| Jun 30, 2024 | -463.00 |
| Mar 31, 2024 | -924.00 |
| Dec 31, 2023 | -886.00 |
| Sep 30, 2023 | -1,040.00 |
| Jun 30, 2023 | -1,196.00 |
| Mar 31, 2023 | -262.00 |
| Dec 31, 2022 | 336.00 |
| Sep 30, 2022 | 214.00 |
| Jun 30, 2022 | 147.00 |
| Mar 31, 2022 | -825.00 |
| Dec 31, 2021 | 276.00 |
| Sep 30, 2021 | 192.00 |